Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.82 - $7.7 $204,353 - $326,456
-42,397 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.0 - $16.98 $65,400 - $185,082
10,900 Added 34.61%
42,397 $278,000
Q4 2021

Feb 15, 2022

BUY
$15.19 - $29.33 $17,833 - $34,433
1,174 Added 3.87%
31,497 $516,000
Q3 2021

Nov 15, 2021

BUY
$27.35 - $37.28 $829,334 - $1.13 Million
30,323 New
30,323 $881,000

Others Institutions Holding ZYME

About Zymeworks Inc.


  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $872M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.